The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Dovitinib in first-line renal cell carcinoma: An investigation into tumour gene status and correlation with efficacy: A phase II clinical trial.
Reuben James Broom
No relevant relationships to disclose
Steven Duffey
No relevant relationships to disclose
Carol Fraser-Browne
No relevant relationships to disclose
Georgia Wilson
No relevant relationships to disclose
Kerin Thompson
No relevant relationships to disclose
Fritha Hanning
No relevant relationships to disclose
Nicola Jane Mitchell
No relevant relationships to disclose
Jonathan Zwi
No relevant relationships to disclose
Mark James McKeage
No relevant relationships to disclose
George Dranitsaris
No relevant relationships to disclose
Paul Oei
No relevant relationships to disclose
Peter C.C. Fong
No relevant relationships to disclose